EyePoint Pharmaceuticals (EYPT) 8-K Summary

Date of Report: November 5, 2025

EyePoint Pharmaceuticals filed an 8-K to report financial results for the fiscal quarter ended September 30, 2025.

• Material Information: The specific financial performance details (revenue, earnings, etc.) are contained within the furnished press release, Exhibit 99.1.
• The company is registered on the Nasdaq Global Market under the ticker EYPT.
• The report was signed by George O. Elston, EVP and CFO.

Investors must refer to Exhibit 99.1 for critical quarterly metrics and oper